Replies to post #690334 on NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

TTsr, Agreed. I welcome more NWBO retail investors. More the merrier. How often does retail get to exact financial karma on market manipulators and front-run institutional investor's buying. It is almost always the other way around.

Unique set of circumstances
- NWBO is a unicorn company that changes the landscape of cancer therapy.
- Stock price is manipulated to an extremely low price. Intrinsic value is giant and continually growing.
- A vaccine (efficacy + immune memory = cancer cure). That changes everything.
- Regulatory approval within week(s).
- Institutions can't buy yet, shorts can't cover yet.
- A retail $0.50 buy can become a $10 punch to the guts of shorts covering.
- A long term, above average high growth investment

All IMHHHO (HHHO=humble hopeful happy opinion)